Predictors of outcomes after nontraumatic subdural hematoma

Subdural Hematoma: Predictors of Outcome and a Score to Guide Surgical Decision-Making

“…The management of SDH is controversial in the absence of evidence-based guidelines and randomized controlled trials. Numerous prior studies have identified predictors of outcome, such as age, co-morbidities and SDH evacuation, [13][14][15][16][17][18][19][20][21][22][23][24][25] however these studies are limited by factors such as small sample size, heterogeneity in management, variable outcome measures, and most importantly, confounders that influence surgical decision-making and hence clinical outcome. In this relatively large single-center study, we investigated the association between SDH evacuation and outcome while controlling for potential confounding by indication.…”

Evaluation of Chronic Subdural Hematoma Volume Calculated via Cavalieri’s Principle

“…The most common cause of SDH is head trauma and the history of trauma was 72% in Borger et al study (36) and 66.7% in our study. Studies have reported midline shift in 86% of patients with CSDH and 61% of patients with nontraumatic CSDH (37,38). In 54.5% of our patients, midline shift was detected.…”

“…No statistically significant difference was determined between midline shift and hematoma volume and percentage values in our study. Schneck et al and Saritas et al reported that 63% and 86% of patients with subdural hematoma underwent surgical evacuation (19,38). It was determined in the present study that 66,7% of the patients were treated with surgery.…”

Fast Point-of-Care Coagulometer Guided Reversal of Oral Anticoagulation at the Bedside Hastens Management of Acute Subdural Hemorrhage

“…In these patients, major bleedings are reported to occur at a rate of up to 3.4% per year [3] and the rate of intracranial bleedings amounts to up to 0.7% per year [3]. Particularly, nontraumatic subdural hemorrhage (SDH) is a severe complication of OAC therapy [4,5], associated with a mortality of between 25 and 56% [4,6] and with substantial morbidity [4,7].…”

“…In patients on vitamin K antagonists who suffer from acute or subacute SDH, rapid reversal of the anticoagulatory effect of OAC is important because hematoma expansion can be life-threatening, and emergency hematoma evacuation is frequently necessary to prevent lobar or transtentorial herniation [7]. In most centers coagulation is rapidly normalized in OAC-SDH patients, but it is still unclear which regimen should be followed [8].…”